233
Views
32
CrossRef citations to date
0
Altmetric
Original

Hydrocaffeic and p-coumaric acids, natural phenolic compounds, inhibit UV-B damage in WKD human conjunctival cells in vitro and rabbit eye in vivo

, , &
Pages 903-910 | Received 21 Jul 2008, Published online: 07 Jul 2009
 

Abstract

This paper studied the effect on UV-B ocular damage of 10µm hydrocaffeic acid (HCAF) alone and as a mixture (MIX) (5µm HCAF+5µm p-coumaric acid). Since ocular UV-B damage is mediated by reactive oxygen species, the aim was to test if HCAF and MIX could reduce oxidation damage in human conjunctival cells (WKD) in vitro and in cornea and sclera of rabbits in vivo. After UVB irradiation (44 J/m2) of WKD cells, 8-oxodG levels in DNA were markedly increased and this effect was attenuated by HCAF and MIX. Rabbit eyes were treated by application of HCAF and MIX drops before UV-B exposure (79 J/m2). Corneal and scleral DNA oxidation damage, xanthine-oxidase (XO) activity and malondialdehyde levels (MDA) in corneal tissue and prostaglandin E2 (PGE2) in the aqueous humour were reduced by HCAF alone and in combination with p-coumaric acid, showing their potential as a topical treatment against UV-B damage.

Abbreviations
UV-B=

Ultraviolet B radiation

ROS=

Reactive oxygen species

8-oxodG=

8-oxo-2’-deoxyguanosine

dG=

2’-deoxyguanosine

p-COUM=

p-coumaric acid

HCAF=

hydrocaffeic acid

DNPH=

2,4-dinitrophenylhydrazine

TEP=

1,1,3,3-tetraethoxypropane

WKD=

Wong Kilbourne derived cells

MDA=

Malonyldialdehyde

PBS=

Phosphate buffer solution.

Abbreviations
UV-B=

Ultraviolet B radiation

ROS=

Reactive oxygen species

8-oxodG=

8-oxo-2’-deoxyguanosine

dG=

2’-deoxyguanosine

p-COUM=

p-coumaric acid

HCAF=

hydrocaffeic acid

DNPH=

2,4-dinitrophenylhydrazine

TEP=

1,1,3,3-tetraethoxypropane

WKD=

Wong Kilbourne derived cells

MDA=

Malonyldialdehyde

PBS=

Phosphate buffer solution.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.